The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis.

Saved in:
Bibliographic Details
Title: The Autoimmune Risk R262W Variant of the Adaptor SH2B3 Improves Survival in Sepsis.
Authors: Allenspach EJ; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; drawling@uw.edu ealle2@uw.edu.; Department of Pediatrics, University of Washington, Seattle, WA., Shubin NJ; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA., Cerosaletti K; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA., Mikacenic C; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA.; Department of Medicine, Division of Pulmonary and Critical Care, University of Washington, Seattle, WA., Gorman JA; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA., MacQuivey MA; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA., Rosen ABI; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA., Timms AE; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA., Wray-Dutra MN; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA., Niino K; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA., Liggitt D; Department of Comparative Medicine, University of Washington, Seattle, WA., Wurfel MM; Department of Medicine, Division of Pulmonary and Critical Care, University of Washington, Seattle, WA., Buckner JH; Center for Translational Immunology, Benaroya Research Institute at Virginia Mason, Seattle, WA.; Department of Immunology, University of Washington, Seattle, WA., Piliponsky AM; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA.; Department of Pediatrics, University of Washington School of Medicine, Seattle, WA.; Department of Pathology, University of Washington School of Medicine, Seattle, WA; and.; Department of Global Health, University of Washington School of Medicine, Seattle, WA., Rawlings DJ; Center for Immunity and Immunotherapies, Seattle Children's Research Institute, Seattle, WA; drawling@uw.edu ealle2@uw.edu.; Department of Pediatrics, University of Washington, Seattle, WA.; Department of Immunology, University of Washington, Seattle, WA.
Source: Journal of immunology (Baltimore, Md. : 1950) [J Immunol] 2021 Dec 01; Vol. 207 (11), pp. 2710-2719. Date of Electronic Publication: 2021 Nov 05.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 2985117R Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1550-6606 (Electronic) Linking ISSN: 00221767 NLM ISO Abbreviation: J Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1550-6606
DOI:10.4049/jimmunol.2100454